ICYMI: Last week's issue of @science.org featured some very cool work sitting at the intersection of #Type2Immunity & #neuroimmunology from @danhkaplan.bsky.social & colleagues! Check it out!
#Immunology out now @science.org
Scratching in mice promotes pain-sensing neurons to release a neuropeptide that stimulated antigen-activated mast cells to degranulate and produce inflammatory mediators.
https://buff.ly/4hDAgF2
From Andrew Liu, @danhkaplan.bsky.social et al
Scratching in mice promotes pain-sensing neurons to release a neuropeptide that stimulated antigen-activated mast cells to degranulate and produce inflammatory mediators.
https://buff.ly/4hDAgF2
From Andrew Liu, @danhkaplan.bsky.social et al
February 6, 2025 at 6:20 PM
ICYMI: Last week's issue of @science.org featured some very cool work sitting at the intersection of #Type2Immunity & #neuroimmunology from @danhkaplan.bsky.social & colleagues! Check it out!
Ghreetings from ghorgeous Ghent, where #Type2Immunity26 co-org by @vibtrainconf.bsky.social & #Science #Immunology is well under way! Check out our free collection of #allergy, #asthma, & #Type2Immunity papers in celebration!
Collection: bit.ly/SciImm_free
Conference: vibbio.tech/3UwmTNk
Collection: bit.ly/SciImm_free
Conference: vibbio.tech/3UwmTNk
March 9, 2026 at 2:04 PM
Ghreetings from ghorgeous Ghent, where #Type2Immunity26 co-org by @vibtrainconf.bsky.social & #Science #Immunology is well under way! Check out our free collection of #allergy, #asthma, & #Type2Immunity papers in celebration!
Collection: bit.ly/SciImm_free
Conference: vibbio.tech/3UwmTNk
Collection: bit.ly/SciImm_free
Conference: vibbio.tech/3UwmTNk
🤩🤩🤩 Fantastic talk of @profjudiallen.bsky.social this morning #EMDS2024 with super cool unpublished data and B cell Macrophage interactions during worm infections. We have so much to learn from in vivo macrophage activation in worm infections! 👏🏻👏🏻👏🏻👏🏻👏🏻 #macrophages #type2immunity
November 27, 2024 at 9:09 AM
🤩🤩🤩 Fantastic talk of @profjudiallen.bsky.social this morning #EMDS2024 with super cool unpublished data and B cell Macrophage interactions during worm infections. We have so much to learn from in vivo macrophage activation in worm infections! 👏🏻👏🏻👏🏻👏🏻👏🏻 #macrophages #type2immunity
Cool new study from Iliev lab at Weill Cornell Medicine showing a #commensalfungi that dominates the mycobiome of wild mice driving #eosinophilia and #type2immunity through the ST2-IL33 axis, resulting in enhanced resistant to helminth infection 👇 www.nature.com/articles/s41...
Fungal symbiont transmitted by free-living mice promotes type 2 immunity - Nature
Kazachstania pintolopesii is a highly prevalent fungal symbiont that can trigger type 2 immunity and influence the composition of the gut mycobiome, as well as immune and disease phenotypes.
www.nature.com
December 1, 2024 at 1:53 AM
Cool new study from Iliev lab at Weill Cornell Medicine showing a #commensalfungi that dominates the mycobiome of wild mice driving #eosinophilia and #type2immunity through the ST2-IL33 axis, resulting in enhanced resistant to helminth infection 👇 www.nature.com/articles/s41...
Type 2 immunity evolved to defend against parasites and support tissue repair, but it also drives allergies/eosinophilic diseases. This review explores the dual role of Type2 immunity in health and disease.
#Immunology #CRS #Allergy #Type2Immunity #Biologics
🔗 ino.to/V0T96Ke
#Immunology #CRS #Allergy #Type2Immunity #Biologics
🔗 ino.to/V0T96Ke
September 10, 2026 at 2:46 PM
Type 2 immunity evolved to defend against parasites and support tissue repair, but it also drives allergies/eosinophilic diseases. This review explores the dual role of Type2 immunity in health and disease.
#Immunology #CRS #Allergy #Type2Immunity #Biologics
🔗 ino.to/V0T96Ke
#Immunology #CRS #Allergy #Type2Immunity #Biologics
🔗 ino.to/V0T96Ke
In partnership with @vibtrainconf.bsky.social, #ScienceImmunology is organizing #Type2Immunity26 in Ghent 9–10 March 2026, bringing together leaders in the field of #Type2Immunity.
Check out our lineup here: vibbio.tech/3UwmTNk
🗓️15 DEC: Travel grant deadline
🗓️8 JAN: Abstract deadline
Check out our lineup here: vibbio.tech/3UwmTNk
🗓️15 DEC: Travel grant deadline
🗓️8 JAN: Abstract deadline
December 12, 2025 at 2:39 PM
In partnership with @vibtrainconf.bsky.social, #ScienceImmunology is organizing #Type2Immunity26 in Ghent 9–10 March 2026, bringing together leaders in the field of #Type2Immunity.
Check out our lineup here: vibbio.tech/3UwmTNk
🗓️15 DEC: Travel grant deadline
🗓️8 JAN: Abstract deadline
Check out our lineup here: vibbio.tech/3UwmTNk
🗓️15 DEC: Travel grant deadline
🗓️8 JAN: Abstract deadline
Primary sensory neurons of the ENS respond directly to type 2 cytokines by upregulating NMU and CGRPβ, shaping intestinal immune responses and promoting helminth clearance. #NeuroImmune #ENS #Type2Immunity
buff.ly
May 29, 2025 at 4:01 PM
Primary sensory neurons of the ENS respond directly to type 2 cytokines by upregulating NMU and CGRPβ, shaping intestinal immune responses and promoting helminth clearance. #NeuroImmune #ENS #Type2Immunity
To celebrate next week's #Type2Immunity26 meeting in Ghent co-org by @vibtrainconf.bsky.social & #Science #Immunology, we've selected 8 recent #allergy, #asthma, & #Type2Immunity papers. Free collection available until end April 2026!
Collection: bit.ly/SciImm_free
Conference: vibbio.tech/3UwmTNk
Collection: bit.ly/SciImm_free
Conference: vibbio.tech/3UwmTNk
March 3, 2026 at 10:47 AM
To celebrate next week's #Type2Immunity26 meeting in Ghent co-org by @vibtrainconf.bsky.social & #Science #Immunology, we've selected 8 recent #allergy, #asthma, & #Type2Immunity papers. Free collection available until end April 2026!
Collection: bit.ly/SciImm_free
Conference: vibbio.tech/3UwmTNk
Collection: bit.ly/SciImm_free
Conference: vibbio.tech/3UwmTNk
Thank you to @bsfcharity.bsky.social @wellcometrust.bsky.social @cancerresearchuk.org for funding the study and @thejidjournal.bsky.social for a smooth publishing process! @imperialimmuno.bsky.social #eosinophils #skin #cSCC #type2immunity
May 27, 2025 at 11:18 AM
Thank you to @bsfcharity.bsky.social @wellcometrust.bsky.social @cancerresearchuk.org for funding the study and @thejidjournal.bsky.social for a smooth publishing process! @imperialimmuno.bsky.social #eosinophils #skin #cSCC #type2immunity
A 16-week #dupilumab 💊 regimen for young kids with eczema restored skin barrier and suppressed local Th2 inflammation 🔥, with machine learning pinpointing new redox-related treatment targets 🎉
#Immunology #biologics #type2immunity #redox #ML
🔗 ino.to/2rLyiTE
#Immunology #biologics #type2immunity #redox #ML
🔗 ino.to/2rLyiTE
Dupilumab in Children Under 6 Years With Moderate‐to‐Severe Atopic Dermatitis: A 16‐Week Real‐World Prospective Study on Efficacy, Safety, and Local‐Systemic Immune Responses
Sixteen-week dupilumab improved clinical outcomes in young children with AD, restoring skin barrier and suppressing local Th2 inflammation. However, persistent systemic inflammation suggests a need f...
ino.to
October 8, 2025 at 9:59 AM
A 16-week #dupilumab 💊 regimen for young kids with eczema restored skin barrier and suppressed local Th2 inflammation 🔥, with machine learning pinpointing new redox-related treatment targets 🎉
#Immunology #biologics #type2immunity #redox #ML
🔗 ino.to/2rLyiTE
#Immunology #biologics #type2immunity #redox #ML
🔗 ino.to/2rLyiTE
Type 2 inflammation‐biased arachidonic acid metabolite regulates mucosal remodeling of Chronic Rhinosinusitis with nasal polyps
#Immunology #CRSwNP #Type2immunity #metabolomics
🔗 ino.to/Q4zxU7z
#Immunology #CRSwNP #Type2immunity #metabolomics
🔗 ino.to/Q4zxU7z
Type 2 Inflammation‐Biased Arachidonic Acid Metabolite Regulates Mucosal Remodeling of Chronic Rhinosinusitis With Nasal Polyps
Our data indicate that patients with ECRSwNP exhibit elevated levels of type 2 inflammation, which upregulates ALOX15 expression, resulting in increased metabolism of arachidonic acid to 15(S)-HETE. ....
ino.to
March 19, 2026 at 5:01 PM
Type 2 inflammation‐biased arachidonic acid metabolite regulates mucosal remodeling of Chronic Rhinosinusitis with nasal polyps
#Immunology #CRSwNP #Type2immunity #metabolomics
🔗 ino.to/Q4zxU7z
#Immunology #CRSwNP #Type2immunity #metabolomics
🔗 ino.to/Q4zxU7z
Another pre-print now out from the Everts' Group! For those interested in #immunometabolism #DendriticCells #Type2Immunity. Post-translational O-GlcNAcylation is a process required selectively for Th2 priming by DC.
www.biorxiv.org/content/10.6...
www.biorxiv.org/content/10.6...
www.biorxiv.org
February 6, 2026 at 7:27 AM
Another pre-print now out from the Everts' Group! For those interested in #immunometabolism #DendriticCells #Type2Immunity. Post-translational O-GlcNAcylation is a process required selectively for Th2 priming by DC.
www.biorxiv.org/content/10.6...
www.biorxiv.org/content/10.6...
#Type2Immunity helps maintain tissue balance and shapes many key decisions. It guides repair, protects us, and at times causes disease.
Want to add to the discussion and take your science on the road?
TODAY is your last chance to apply for a #Type2Immunity26 travel grant: vibbio.tech/4pPXr2K
Want to add to the discussion and take your science on the road?
TODAY is your last chance to apply for a #Type2Immunity26 travel grant: vibbio.tech/4pPXr2K
December 15, 2025 at 9:33 AM
#Type2Immunity helps maintain tissue balance and shapes many key decisions. It guides repair, protects us, and at times causes disease.
Want to add to the discussion and take your science on the road?
TODAY is your last chance to apply for a #Type2Immunity26 travel grant: vibbio.tech/4pPXr2K
Want to add to the discussion and take your science on the road?
TODAY is your last chance to apply for a #Type2Immunity26 travel grant: vibbio.tech/4pPXr2K
R. Jiménez-Saiz, S. Iborra, C. Blanco, et al., “ Understanding the Type 2 Immunity: An Evolving View Beyond Allergic Diseases,” 👉 doi.org/10.1111/all.70512.
#EpithelialBarrier #Type2Immunity #Allergy #Immunology #Microbiome
epithelialbarriertheory.com
#EpithelialBarrierTheory
#EpithelialBarrier #Type2Immunity #Allergy #Immunology #Microbiome
epithelialbarriertheory.com
#EpithelialBarrierTheory
September 10, 2026 at 7:42 PM
R. Jiménez-Saiz, S. Iborra, C. Blanco, et al., “ Understanding the Type 2 Immunity: An Evolving View Beyond Allergic Diseases,” 👉 doi.org/10.1111/all.70512.
#EpithelialBarrier #Type2Immunity #Allergy #Immunology #Microbiome
epithelialbarriertheory.com
#EpithelialBarrierTheory
#EpithelialBarrier #Type2Immunity #Allergy #Immunology #Microbiome
epithelialbarriertheory.com
#EpithelialBarrierTheory
The clock is ticking! Your insights into #Type2Immunity could be the next big discovery. Your research can shift paradigms. Don’t miss your chance; abstracts are due today for #Type2Immunity26. Organized in partnership with @science.org.
Submit it here: vibbio.tech/4pw9YYG
Submit it here: vibbio.tech/4pw9YYG
January 8, 2026 at 12:29 PM
The clock is ticking! Your insights into #Type2Immunity could be the next big discovery. Your research can shift paradigms. Don’t miss your chance; abstracts are due today for #Type2Immunity26. Organized in partnership with @science.org.
Submit it here: vibbio.tech/4pw9YYG
Submit it here: vibbio.tech/4pw9YYG
Curious about the science shaping the future of #Type2immunity? Or about the key role played by therapeutic strategies targeting type 2 pathways?
Join our #Type2Immunity26 and meet the organizing committee, bringing together bright minds to spark new conversations: vibbio.tech/4oDo0aN.
#VIBConf
Join our #Type2Immunity26 and meet the organizing committee, bringing together bright minds to spark new conversations: vibbio.tech/4oDo0aN.
#VIBConf
November 4, 2025 at 11:35 AM
Curious about the science shaping the future of #Type2immunity? Or about the key role played by therapeutic strategies targeting type 2 pathways?
Join our #Type2Immunity26 and meet the organizing committee, bringing together bright minds to spark new conversations: vibbio.tech/4oDo0aN.
#VIBConf
Join our #Type2Immunity26 and meet the organizing committee, bringing together bright minds to spark new conversations: vibbio.tech/4oDo0aN.
#VIBConf
August 25, 2025 at 11:22 AM